Physician profile
Robert Mccurley
NPI 1154362168
$1,826.88
in general payments reported to CMS, 2019-2025
22 companies · $271 in 2025
The $271 reported for 2025 was more than what 82% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $259 · 2020: $26.41 · 2022: $167 · 2023: $527 · 2024: $576 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,374.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $439.63 | 2022-2025 | Azstarys |
| Glaxosmithkline, LLC. | $197.19 | 2019-2025 | Bexsero, Pediarix |
| Supernus Pharmaceuticals, INC. | $196.38 | 2023-2024 | Qelbree, Qelbree |
| Pfizer INC. | $170.72 | 2019-2025 | |
| Sanofi Pasteur INC. | $166.30 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $126.13 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Arbor Pharmaceuticals, INC. | $77.10 | 2019 | |
| Ironshore Pharmaceuticals INC. | $74.90 | 2019-2024 | |
| Ars Pharmaceuticals Operations, INC. | $56.92 | 2025 | Neffy |
| Sobi, INC | $53.87 | 2022-2023 | |
| Genentech USA, INC. | $44.52 | 2019 | |
| Modernatx, INC. | $43.70 | 2023 | Moderna Covid-19 Vaccine |
| Jazz Pharmaceuticals INC. | $31.21 | 2024 | |
| Biomarin Pharmaceutical INC. | $30.11 | 2024 | Voxzogo 1.2mg |
| Acadia Pharmaceuticals INC | $19.88 | 2025 | Daybue |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $18.51 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $17.20 | 2022 | |
| Seqirus USA INC | $15.07 | 2025 | Flucelvax |
| Takeda Pharmaceuticals U.S.A., INC. | $14.17 | 2020 | |
| Shire North American Group INC | $14.08 | 2019 | |
| Collegium Pharmaceutical, INC. | $13.83 | 2025 | Jornay Pm |
| Ossur Americas, INC. | $5.46 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Mccurley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.